Skip to main content

$0.077 -0.003 (-3.75%)

High

$0.08

Low

$0.08

Trades

6

Turnover

$17,007

Volume

211,355
30 June 2023 at 1:01pm
Register to track PEB and receive email alerts.

Clinical Study Advancing Cxbladder as standard of care

StockBot

416,823 posts

PEB released this announcement to the ASX on 10 May 2022, 8:32. The announcement is not marked as price sensitive, and is 3 page(s) in length and 681.02kb in size.

You can view all announcements from PEB and see how they appear on a price chart on the announcements page.

At the date of this announcement, PEB was 0.028% short sold according to ASIC data. It was ranked the 586th most shorted stock on the ASX. It is now ranked as the 462nd most shorted stock on the ASX with 0.091% of total shares short sold as of the latest reported data (26 May 2026).

Other Recent Announcements from PEB
Notice of Annual General Meeting/Proxy Form 26 June 2023, 14:10
Annual Report to shareholders 22 June 2023, 7:49
Medicare Coverage of Cxbladder Expected to Cease 7 June 2023, 8:37
Clinical Study Advancing Cxbladder as standard of care 10 May 2022, 8:32
Pacific Edge Full Year Result to be Announced 26 May 2022 3 May 2022, 10:17
D&O Disclosure - NZX - D Darling 28 April 2022, 12:47
Capital Change Notice - NZX 26 April 2022, 13:00
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track PEB and receive email alerts.